← Back to Search

Acupressure for Gastrointestinal Cancers

N/A

Waitlist Available

Led By Blake Langley

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with stage II-IV gastric, esophageal, or pancreatic cancer

At least 60 days of planned systemic treatment, whether already initiated or scheduled to be initiated

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 15 months

Awards & highlights

Study Summary

This trial looks at using acupressure to the ear to help cancer patients with appetite and weight loss. It may help improve quality of life and reduce side effects of treatments.

Who is the study for?

This trial is for adults aged 18-65 with stage II-IV gastric, esophageal, or pancreatic cancer who have appetite issues. Participants need access to a phone and electronic device, must not be on certain medications for appetite stimulation, and should not have had acupressure or acupuncture in the last month. They must be able to eat orally and commit to attending treatments at a specific clinic as well as performing self-applied treatments.Check my eligibility

What is being tested?

The study tests auricular acupressure's ability to improve appetite and weight in patients with advanced digestive cancers. It involves sticking small pellets onto the ear that are believed to stimulate the nervous system. Patients will receive this non-invasive treatment both at a clinic and by themselves at home.See study design

What are the potential side effects?

Auricular acupressure is generally safe with minimal risk of side effects since it's non-invasive. However, some may experience minor discomfort or skin irritation where the pellets are applied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with stage II-IV gastric, esophageal, or pancreatic cancer.

Select...

I am on or will start a treatment plan that lasts at least 60 days.

Select...

My outer ear is normal and undamaged.

Select...

I am between 18 and 65 years old.

Select...

I do not have any known immune system disorders.

Select...

I am not using steroids or immune system drugs to increase my appetite.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 15 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 15 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 15 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability (feasibility)

Accrual (feasibility)

Intervention adherence (feasibility)

+2 more

Secondary outcome measures

Change in appetite

Change in body weight (kg)

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (acupressure therapy)Experimental Treatment4 Interventions

Patients undergo auricular acupressure in addition to their usual care on study. Patients also undergo collection of blood samples on study.

Group II: Arm II (usual care)Active Control3 Interventions

Patients receive usual care on study. Patients also undergo collection of blood samples on study.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Biospecimen Collection

2004

Completed Phase 2

~1730

0 / 6Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH

321 Previous Clinical Trials

401,683 Total Patients Enrolled

University of WashingtonLead Sponsor

1,740 Previous Clinical Trials

1,847,604 Total Patients Enrolled

National Center for Complementary and Integrative Health (NCCIH)NIH

832 Previous Clinical Trials

668,867 Total Patients Enrolled

Media Library

Auricular Acupressure Clinical Trial Eligibility Overview. Trial Name: NCT05911243 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to take part in this medical experiment?

"The necessary criteria to be eligible for this clinical trial is esophageal adenocarcinoma and a patient age between 18 and 65 years old. Currently, the medical team is seeking 66 individuals that meet these requirements."

Answered by AI

Do participants of this research have to be younger than thirty?

"This medical trial has a lower age limit of 18 and an upper age bound set at 65, as specified by the enrollment criteria."

Answered by AI

Are there any available slots left for this research endeavor?

"This research endeavour, which was first made public on November 1st 2023, is not currently enrolling subjects. Nonetheless, there are over 4000 other clinical trials actively searching for volunteers at this moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer

2024. "Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05911243.

All > Gastric Cancer